Drug Type miRNA |
Synonyms- |
Target |
Mechanism miR-155 antagonists(microRNA 155 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Wet Macular Degeneration | Preclinical | CN | 10 Sep 2020 |